Eyck Freymann: How to Break China’s Minerals Chokehold
Why the allies need a multilateral commercial stockpile This essay is based on a Hoover History Lab working paper, co-authored with Joshua Stinson, William Norris,…
Thought Leader: Eyck Freymann
Behind the HHS-CDC Disagreement
By Scott Gottlieb (original source The Wall Street Journal)
“The Covid epidemic in the South has strained the country’s capacity to keep up with the demand for testing. Six months into the pandemic, we still don’t have enough supplies, equipment or lab services. There’s no national plan for effectively allocating the capacity that does exist or providing a sufficient surge where it’s needed suddenly.
The system is overwhelmed. Major commercial labs are reporting turnaround times of around seven days, and patients say it’s often longer. Without a confirmed diagnosis, many infected patients don’t isolate themselves or get treatments.
The intelligence community has warned for years that pandemic disease was a national-security threat on par with that of terrorism, weapons of mass destruction and cyberattacks. It’s essential to increase American capacity to detect these events, contain them, and manufacture reliable countermeasures.”
Click here to read more
Relevant and recent posts
Chris Miller: Robotics Manufacturing: The Rise of Japan
“To the Americans, a robot is a computer attached to a mechanism. To Japanese, a robot is a mechanism attached to a computer.” The future…
Thought Leader: Chris Miller
Dr. Sanjay Gupta: A New Understanding of Parkinson’s Disease
Parkinson’s disease, a progressive movement disorder whose hallmark is damage to the dopamine-producing neurons in the brain, afflicts almost 12 million people worldwide. And the…
Thought Leader: Sanjay Gupta
More with this speaker
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb
Scott Gottlieb: China’s edge over U.S. biotech
Thought Leader: Scott Gottlieb